Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson's disease

Movement Disorders

Volumn 26, Issue 13, 2011, Pages 2434-2436

  Tripoliti, Elina ^a   Strong, Laura ^a   Hickey, Freya ^a   Foltynie, Tom ^a   Zrinzo, Ludvic ^a   Candelario, Joseph ^a   Hariz, Marwan ^a   Limousin, Patricia ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

LSVT; Parkinson's disease; Speech; STN DBS

Indexed keywords

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DYSARTHRIA; HUMAN; LEE SILVERMAN VOICE TREATMENT; LOUDNESS; PARKINSON DISEASE; PERCEPTION; PHONATION; PRIORITY JOURNAL; SPEECH INTELLIGIBILITY; SPEECH THERAPY; SUBTHALAMIC NUCLEUS;

DEEP BRAIN STIMULATION; DYSARTHRIA; HUMANS; MIDDLE AGED; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; SPEECH THERAPY; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 81955161958     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23887     Document Type: Article

References (24)

1. Logemann JA, Fisher HB, Boshes B, Blonsky ER. Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. J Speech Hear Disord. 1978; 43: 47-57.
2. Tripoliti E, Zrinzo L, Martinez-Torres I, et al. Effects of subthalamic nucleus deep brain stimulation on speech of consecutive patients with Parkinson's disease. Neurology. 2011; 76: 80-86.
3. Pinto S, Ozsancak C, Tripoliti E, Thobois S, Limousin-Dowsey P, Auzou P. Treatments for dysarthria in Parkinson's disease. Lancet Neurol. 2004; 3: 547-556.
4. Ramig LO, Countryman S, Thompson LL, Horii Y. Comparison of two forms of intensive speech treatment for Parkinson's disease. J Speech Hear Res. 1995; 38: 1232-1251.
5. Ramig LO, Fox C. LSVT®LOUd Trianing and Certification manual. Tucson, AZ: LSVT Global, Inc.
6. Ramig LO, Sapir S, Countryman S, et al. Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up. J Neurol Neurosurg Psychiatry. 2001; 71: 493-498.
7. Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 1998; 339: 1105-1111.
8. Tripoliti E, Limousin P, Tisch S, Borrell E, Hariz MI. Speech in Parkinson's disease following subthalamic nucleus deep brain stimulation: preliminary results. J Med Speech Lang Pathol. 2006; 14: 09-315.
9. Klostermann F, Ehlen F, Vesper J, et al. Effects of subthalamic nucleus deep brain stimulation on dysarthrophonia in Parkinson's Disease. J Neurol Neurosurg Psychiatry. 2008; 79: 522-529.
10. Hartinger M, Tripoliti E, Hardcastle WJ, Limousin P. Effects of medication and subthalamic nucleus deep brain stimulation on tongue movements in speakers with Parkinson's disease using electropalatography: a pilot study. Clin Linguist Phon. 2011; 25: 210-230.
11. Yorkston K, Beukelman D. Assessment of Intelligibility of Dysarthric Speech. Austin, TX: Pro-ed; 1984.
12. Tripoliti E, Zrinzo L, Martinez-Torres I, et al. Effects of contact location and voltage amplitude on speech and movement in bilateral subthalamic nucleus deep brain stimulation. Mov. Disord. 2008; 23: 2377-2383.
13. Darley FL, Aronson AE, Brown JR. Motor Speech Disorders. Philadelphia: W.B. Saunders Company; 1975.
14. Plowman-Prine EK, Okun MS, Sapienza CM, et al. Perceptual characteristics of Parkinsonian speech: a comparison of the pharmacological effects of levodopa across speech and non-speech motor systems. Neurorehabilitation. 2009; 24: 131-144.
15. Ramig LO, Sapir S, Fox C, Countryman S. Changes in vocal loudness following voice treatment (LSVT) in individuals with Parkinson's disease: a comparison with untreated patients and normal age-matched controls. Mov Disord. 2001; 16: 79-83.
16. Fox C & Ramig L. Vocal sound pressure level and self-perception of speech in men and women with idiopathic Parkinson disease. Am J Speech Lang Pathol 1997; 6: 85-94.
17. Spielman J, Ramig L, Will L, Halpern A, Petska J. Effects of LSVT-Extended (LSVT-X) on voice and speech in Parkinson disease. Am J Speech Lang Pathol. 2007; 16: 95-107.
18. Alberts JL, Voelcker-Rehage C, Hallahan K, Vitek M, Bamzai R, Vitek JL. Bilateral subthalamic stimulation impairs cognitive-motor performance in PD patients. Brain. 2008; 131: 3348-3360.
19. Frankemolle AM, Wu J, Noecker AM, et al. Reversing cognitive-motor impairments in Parkinson's disease patients using a computational modeling approach to deep brain stimulation programming. Brain. 2010; 133: 746-761.
20. Trail M, Fox C, Ramig LO, Sapir S, Howard J, Lai EC. Speech treatment for Parkinson's disease. Neurorehabilitation. 2005; 20; 205-221.
21. Nieuwboer A, Rochester L, Muncks L, Swinnen SP. Motor Learning in Parkinson's disease: limitations and potential for rehabilitation. Parkinsonism Relat Disord. 2009; 15S3: S53-S58.
22. Sapir S, Ramig L, Hoyt P, O'Brien C, Hoehn M. Speech loudness and quality 12 months after intensive voice treatment (LSVT) for Parkinson's disease: a comparison with an alternative speech treatment. Folia Phoniatrica. 2002; 54: 296-303.
23. Sapir S, Spielman J, Countryman S, et al. Phonatory and articulatory changes in ataxic dysarthria following intensive voice therapy with the LSVT®: a single subject study. Am J Speech Lang Pathol. 2003; 12: 387-399.
24. Sapir S, Spielman JL, Ramig LO, Story BH, Fox C. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings. J Speech Lang Hear Res. 2007; 50: 899-912.